![Nicholas N. Vahanian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas N. Vahanian
Plus aucun poste en cours
Profil
Nicholas N.
Vahanian was the founder who founded NewLink Genetics Corp.
in 1999 and held the titles of President, Director & Chief Medical Officer from 2015 to 2017.
He also worked as President at Lumos Pharma, Inc. in a former job.
Dr. Vahanian earned an MBA degree from the University of Notre Dame and an undergraduate degree from Virginia Commonwealth University.
Anciens postes connus de Nicholas N. Vahanian
| Sociétés | Poste | Fin |
|---|---|---|
| LUMOS PHARMA, INC. | Fondateur | 11/11/2019 |
| LUMOS PHARMA, INC. | President | 27/09/2019 |
Formation de Nicholas N. Vahanian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
23
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Commonwealth University
 Virginia Commonwealth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
